Overactive Bladder - Results from #1400

OnabotulinumtoxinA in overactive bladder: Evidence-based consensus recommendations - Abstract June 25, 2015

Efficacy of tadalafil once daily versus fesoterodine in the treatment of overactive bladder in older patients - Abstract June 25, 2015

Management and rehabilitation of neurologic patients with lower urinary tract dysfunction - Abstract June 23, 2015

Management of refractory overactive bladder in children by transcutaneous posterior tibial nerve stimulation: A controlled study - Abstract June 22, 2015

Lower urinary tract dysfunction in patients with multiple sclerosis - Abstract June 20, 2015

Lower urinary tract dysfunction in patients with brain lesions - Abstract June 19, 2015

Sexual and bladder comorbidity in women - Abstract June 17, 2015

Comparative effectiveness of anticholinergic therapy for overactive bladder in women: A systematic review and meta-analysis - Abstract June 16, 2015

Is self-reported adherence associated with clinical outcomes in women treated with anticholinergic medication for overactive bladder? - Abstract June 15, 2015

Antimuscarinics in the treatment of OAB: Is there a first-line and a second-line choice? - Abstract June 11, 2015

OnabotulinumtoxinA intradetrusorial injections improve sexual function in female patients affected by multiple sclerosis: Preliminary results - Abstract June 8, 2015

Laparoscopic implantation of neuromodulators for treating urinary dysfunctions and improving locomotion in multiple sclerosis patients - Abstract June 4, 2015

A prospective, comparative study of the occurrence and severity of constipation with darifenacin and trospium in overactive bladder - Abstract June 2, 2015

Overactive bladder symptoms in patients with multiple sclerosis: Frequency, severity, diagnosis and treatment - Abstract May 29, 2015

Abnormal functional connectivity in women with urgency urinary incontinence: Can we predict disease presence and severity in individual women using Rs-fcMRI/ - Abstract May 27, 2015

Patient-reported goal achievement following onabotulinumtoxinA treatment in patients with neurogenic detrusor overactivity - Abstract May 26, 2015

A clinical perspective on the analysis and presentation of the number of incontinence episodes following treatment for OAB - Abstract May 26, 2015

Neuromodulation for overactive bladder symptoms in women utilizing either motor or sensory/motor provocation with a minimum nine-year follow-up - Abstract May 22, 2015

Different number of intravesical onabotulinumtoxinA injections for patients with refractory detrusor overactivity do not affect treatment outcome: A prospective randomized comparative study - Abstract May 21, 2015

Efficacy and safety of onabotulinumtoxinA in treating neurogenic detrusor overactivity: A systematic review and meta-analysis - Abstract May 21, 2015

Page 71 of 122